155 related articles for article (PubMed ID: 34407108)
21. Pharmacists experience of and perspectives about recruiting patients into a community pharmacy asthma service trial.
Bertilsson E; Serhal S; Emmerton L; Bosnic-Anticevich S; Krass I; Bereznicki B; Bereznicki L; Armour C; Saini B
Res Social Adm Pharm; 2021 Mar; 17(3):595-605. PubMed ID: 32448767
[TBL] [Abstract][Full Text] [Related]
22. An exploration of hospital pharmacists' engagement with sustainability policy in the NHS England.
Singleton JA; Lau ET; Nissen LM
Int J Pharm Pract; 2022 Aug; 30(4):383-390. PubMed ID: 35716053
[TBL] [Abstract][Full Text] [Related]
23. Hospital pharmacists' ethical exposure and decision-making.
So B; Tuche M; King MA; Hope DL; La Caze A; Hattingh HL
Res Social Adm Pharm; 2021 Feb; 17(2):372-380. PubMed ID: 32284299
[TBL] [Abstract][Full Text] [Related]
24. 2019 SEFH National Survey: service portfolio, care activities, education and research in Spain's hospital pharmacy departments.
Pérez-Encinas M; Lozano-Blázquez A; García-Pellicer J; Torre-Lloveras I; Poveda-Andrés JL; Calleja-Hernández MÁ
Farm Hosp; 2021 Jan; 45(1):32-40. PubMed ID: 33443476
[TBL] [Abstract][Full Text] [Related]
25. Investigating the challenges and opportunities for medicines management in an NHS field hospital during the COVID-19 pandemic.
de Val J; Sohal G; Sarwar A; Ahmed H; Singh I; Coleman JJ
Eur J Hosp Pharm; 2021 Jan; 28(1):10-15. PubMed ID: 33277234
[TBL] [Abstract][Full Text] [Related]
26. When procedures meet practice in community pharmacies: qualitative insights from pharmacists and pharmacy support staff.
Thomas CE; Phipps DL; Ashcroft DM
BMJ Open; 2016 Jun; 6(6):e010851. PubMed ID: 27266770
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of a survey tool to measure safety climate in Australian hospital pharmacy staff.
Walpola RL; Chen TF; Fois RA; Ashcroft DM; Lalor DJ
Res Social Adm Pharm; 2017; 13(4):789-795. PubMed ID: 27843116
[TBL] [Abstract][Full Text] [Related]
28. What role do pharmacists play in mediating antibiotic use in hospitals? A qualitative study.
Broom A; Broom J; Kirby E; Plage S; Adams J
BMJ Open; 2015 Nov; 5(11):e008326. PubMed ID: 26534731
[TBL] [Abstract][Full Text] [Related]
29. The effectiveness of hospital pharmacy in the UK: methodology for finding the evidence.
Child D; Cantrill J; Cooke J
Pharm World Sci; 2004 Feb; 26(1):44-51. PubMed ID: 15018259
[TBL] [Abstract][Full Text] [Related]
30. Self-reported clinical pharmacy service provision in Austria: an analysis of both the community and hospital pharmacy sector-a national study.
Deibl S; Mueller D; Kirchdorfer K; Stemer G; Hoppel M; Weidmann AE
Int J Clin Pharm; 2020 Aug; 42(4):1050-1060. PubMed ID: 32494989
[TBL] [Abstract][Full Text] [Related]
31. "Convenient space" or "a tight squeeze": insider views on the community pharmacy.
Rapport F; Doel MA; Jerzembek GS
Health Place; 2009 Mar; 15(1):315-22. PubMed ID: 18675577
[TBL] [Abstract][Full Text] [Related]
32. An explanatory model of community pharmacists' support in the secondary prevention of cardiovascular disease.
Puspitasari HP; Costa DSJ; Aslani P; Krass I
Res Social Adm Pharm; 2016; 12(1):104-118. PubMed ID: 26001624
[TBL] [Abstract][Full Text] [Related]
33. Medicine information help lines: a survey of hospital pharmacy-based services in the UK and their conformity with guidelines.
Raynor DK; Sharp JA; Rattenbury H; Towler RJ
Ann Pharmacother; 2000 Jan; 34(1):106-11. PubMed ID: 10669193
[TBL] [Abstract][Full Text] [Related]
34. Exposure to antineoplastic drugs in two UK hospital pharmacy units.
Mason HJ; Blair S; Sams C; Jones K; Garfitt SJ; Cuschieri MJ; Baxter PJ
Ann Occup Hyg; 2005 Oct; 49(7):603-10. PubMed ID: 15964878
[TBL] [Abstract][Full Text] [Related]
35. The issue of moral distress in community pharmacy practice: background and research agenda.
Astbury JL; Gallagher CT; O'Neill RC
Int J Pharm Pract; 2015 Oct; 23(5):361-6. PubMed ID: 25639156
[TBL] [Abstract][Full Text] [Related]
36. Servicescape: physical environment of hospital pharmacies and hospital pharmacists' work outcomes.
Lin BY; Leu WJ; Breen GM; Lin WH
Health Care Manage Rev; 2008; 33(2):156-68. PubMed ID: 18360166
[TBL] [Abstract][Full Text] [Related]
37. Pharmacy, workplace or primary care? Where Australian adults get their influenza vaccines.
Trent MJ; Salmon DA; MacIntyre CR
Aust N Z J Public Health; 2021 Aug; 45(4):385-390. PubMed ID: 33818843
[TBL] [Abstract][Full Text] [Related]
38. Promoting weight management services in community pharmacy: perspectives of the pharmacy team in Scotland.
Weidmann AE; MacLure K; Marshall S; Gray G; Stewart D
Int J Clin Pharm; 2015 Aug; 37(4):599-606. PubMed ID: 25822039
[TBL] [Abstract][Full Text] [Related]
39. Mifepristone (RU486) in Australian pharmacies: the ethical and practical challenges.
Lee RY; Moles R; Chaar B
Contraception; 2015 Jan; 91(1):25-30. PubMed ID: 25248673
[TBL] [Abstract][Full Text] [Related]
40. Continuation of opioid replacement program delivery in the aftermath of cyclones in Queensland, Australia: A qualitative exploration of the perspectives of pharmacists and opioid replacement therapy staff.
O'Dwyer N; Cliffe H; Watson KE; McCourt E; Singleton JA
Res Social Adm Pharm; 2020 Aug; 16(8):1081-1086. PubMed ID: 31753692
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
